Nexinhib 20 improves myocardial ischemia-reperfusion injury by limiting neutrophil recruitment

  • Small molecule that can inhibit myocardial ischemia-reperfusion injury
  • Unmet Need: Treatments that can reduce myocardial ischemia-reperfusion injury as they are critical for treating heart attack patients
  • Technology involves the use a small molecule, Nexinhib20, which has inhibited myocardial ischemia-reperfusion injury in mice

Contact Information

Name: Amit Kumar

Email: a.kumar@uconn.edu

Phone : (860) 486-6938